Programme (UNDP)’s estimate for the annualcost to provide universal safe drinking water andsanitation services ($20-$30 billion). 2Analysts say that the worldwide market growthis driven by the larger number of women over50 years of age, increases in women’s disposableincome and greater male interest in skin care products.<strong>The</strong> skin cream market is particularly strongfor products that make “anti-ageing”, “firming”and “anti-cellulite” claims.Not coincidentally, these claims are precisely thesubject of <strong>Avon</strong>’s patent applications on <strong>Asian</strong><strong>plants</strong>. In 2009, the Asia-Pacific market for suchproducts was 41% of the world total, or about$33 billion, and continued expansion in Asia isconsidered a priority for the industry, 3 which isdominated by US and European companies.<strong>Avon</strong> Products, Inc.With $11 billion in annual sales and a marketcapitalization of over $9 billion, US-based <strong>Avon</strong> isa significant player in the cosmetics and personalcare industries. Founded in 1886, the company wasa pioneer of multi-level marketing and, in manyparts of the world, the “<strong>Avon</strong> <strong>Lady</strong>” is a familiarphenomenon.<strong>The</strong> company pursues a similar business strategyeverywhere, focusing on what industrycalls “direct sales”, by putting women into thebusiness of selling <strong>Avon</strong> products to friends andacquaintances. <strong>The</strong>se saleswomen, in turn, convertsome of their customers into dealers themselves,building and perpetuating a sales chain in whichtransactions largely occur in living rooms andon street corners, rather than in <strong>Avon</strong>-brandedstorefronts.More recently, the company has also started onlineand kiosk sales, especially in countries that haverestrictions on multi-level marketing, includingChina. <strong>The</strong> company has also simplified globalproduct lines, with its current offerings varyinglittle from country to country.<strong>Avon</strong> is profitable, paying an annual dividend ofnearly $1 per share of its stock. Through a charitablefoundation the company claims (in confusingand perhaps misleading language) to be the“largest corporate supporter focused solely on women’sissues across the globe”.<strong>The</strong> company’s marketing tends toward imagesof a “high-tech” product development processled by scientists in laboratory coats at a researchheadquarters in the US state of New York. Althoughnatural products are not the main thrustof <strong>Avon</strong>’s marketing, review of the <strong>Avon</strong> productingredients reveals very frequent use of plantextracts (discussed in more detail below).<strong>Avon</strong> appears eager to expand its skin care offerings.In 2010, it bought UK-based Liz Earle, askin cream company with a different marketingapproach, selling in storefronts and on televisionshopping channels. Botanical ingredients are amatter of emphasis for Liz Earle, whose corporatetagline is “naturally active skincare”.Advertised or not, however, <strong>plants</strong> are animportant part of <strong>Avon</strong>’s skin products.<strong>Avon</strong>’s patent claims on <strong>Asian</strong> <strong>plants</strong><strong>Avon</strong>’s intellectual property claims reveal thecompany to be particularly interested in <strong>Asian</strong><strong>medicinal</strong> and food <strong>plants</strong>. <strong>The</strong> company hasrecently obtained three patents on such <strong>plants</strong>,and three more patent applications are pending.Collectively, the <strong>plants</strong> are associated with countriesacross the region, including Southeast Asia,China and South Asia. In total, claims are madeon the use of 16 different <strong>Asian</strong> <strong>plants</strong> in skin careproducts. <strong>Avon</strong>’s patents and patent applicationsare summarized in the chart on the following page,which includes some of the common names usedfor the <strong>plants</strong> that are claimed.<strong>Avon</strong> appears to be pursuing its claims not only inthe US, Canada, Japan and Europe, but in developingcountries as well. Only limited informationon the international status of patent applicationsis available online. However, the World IntellectualProperty Organization (WIPO)’s Patentscopedatabase indicates that at least three patent applicationshave been lodged in China and two inMexico. More may exist without being reflectedin the WIPO data.<strong>The</strong> <strong>plants</strong> that <strong>Avon</strong> claimsHow <strong>Avon</strong> accessed the <strong>plants</strong> that it claims is notknown. Some, such as Eclipta prostrata, are relativelyubiquitous and could be obtained virtuallyanywhere. Others, such as Stephania rotunda, arefar more likely to be sourced from Asia itself, certainlyif needed in any considerable quantity. Inthe past, <strong>Avon</strong> has maintained company researchersin Asia and relationships with <strong>Asian</strong> academicinstitutions. In all of the patents described here,however, <strong>Avon</strong> company employees based in2
<strong>Avon</strong>’s Objects of Desire: <strong>Asian</strong> Medicinal PlantsPATENT/APPLICATIONNUMBERSWO2012002950US2012003331WO2012005876US20120003332TITLE GENERAL TOPIC PLANT CLAIMUse of Tiliacoratriandra incosmetics andcompositionsthereofCompositionsand methods forstimulatingMAGP-1 toimprove theappearance ofskinSkin care productsSkin care products thatwork by stimulatingproduction ofmicrofibril-associatedglycoprotein 1 (MAGP-1)Use of bai yanang (no English common name), foodand <strong>medicinal</strong> plant used in Laos, Thailand,Vietnam, Cambodia, etc. (dây sng sâm [VN], [LA], [TH]).Claims several <strong>Asian</strong> <strong>plants</strong> that may be used tocreate MAGP-1 skin care products. <strong>The</strong>se are:Antidesma bunius: bignay [PH], buni [MY], wooni[ID], etc.; Operculina turpethum: turpeth, pitohri[IN], St. Thomas lidpod; Ixora chinensis: pechahpriok [MY], siantan [ID], etc.; Clerodendron lindleyi: jian chi xiu mo li [CN]<strong>The</strong> patent application claims additional <strong>plants</strong>when they are mixed with an extract of the above<strong>plants</strong>, or a functionally equivalent chemical.US Pat 7,618,662WO2006068777MX/a/2007/007376JP2007548241EP2005825815CN200580035328.6Use of naturalplant extracts incosmeticscompositionsSkin care products thatwork “to stimulate lipidproduction, adiponectinproduction, adipocytedifferentiation, PPARgammainduction,and/or anycombinations thereof”Claims several <strong>Asian</strong> <strong>plants</strong> that may be used tocreate skin care products of the invention. <strong>The</strong>seare:Humulus scandens: lü cao [CN], widelynaturalized; Amorphophallus campanulatus:elephant foot yam, etc.; Pouzolzia pentandra (syn:Gonostegia pentandra Roxb. Miq.); Rhinacanthusnasutus: snake jasmine, kabutar ka phul [IN], etc.;Sesbania grandiflora: agati, agathi, food plant,widely distributed; Piper betel: betel nutUS Pat 7,514,092WO2006068786CN200580040937.0CA2588128EP2005852369JP2007548242Compositionsand methods oftheir use forimproving thecondition andappearance ofskin“A method ofameliorating, reducing,or treating progressivedegradation of a dermalepidermaljunctionand/or degradation of acell-cell cohesion inskin”Claims several <strong>Asian</strong> <strong>plants</strong> that may be used tocreate skin care products of the invention. <strong>The</strong>seare:Plumbago indica: scarlet leadwort, India native,widely grown; Sapindus rarak: lerak [ID], “soapnut”; Stephania rotunda: bình vôi [VN], “sabooleard”US Pat 7,410,658WO2006068776EP2005825830MX/a/2007/007510CN200580036088.1US20110305781WO2011156136Use of Alismaorientale incosmetics andcompositionsthereofUse of Ecliptaprostrata andother PPAR-GAMMAinhibitors incosmeticsTreatment to reducecelluliteTreatment to reducecelluliteClaims use of Alisma orientale ( dong fangze xie) to treat skin problems.Claims Eclipta prostrata (false daisy) for cellulitetreatment. Widely distributed, with traditional<strong>Asian</strong> <strong>medicinal</strong> use on skin.Note: CN – China; ID – Indonesia; IN – India; LA – Laos; MY – Malaysia; PH – Philippines; TH – Thailand; VN – VietnamNew York are indicated as the inventors, stronglysuggesting that the research and product developmentoccurred there.<strong>The</strong> company’s claims are of varying specificity.All of the claims relate to use of the <strong>Asian</strong> <strong>plants</strong>4in skin care products. Some patent applicationsappear relatively specific, for example, claimingthe use of <strong>plants</strong> to stimulate production of aparticular protein by the skin (e.g., applicationWO2012005876), while others, such as the claimson Tiliacora triandra (WO2012002950), are broader3